Editorial
doi: 10.1161/CIR.0b013e3181d8d929.
Epub 2010 Mar 1.
Role of ticagrelor in clopidogrel nonresponders: resistance is futile?
- PMID: 20194888
- DOI: 10.1161/CIR.0b013e3181d8d929
Item in Clipboard
Editorial
Role of ticagrelor in clopidogrel nonresponders: resistance is futile?
Circulation.
.
No abstract available
Comment on
-
Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study.Circulation. 2010 Mar 16;121(10):1188-99. doi: 10.1161/CIRCULATIONAHA.109.919456. Epub 2010 Mar 1. Circulation. 2010. PMID: 20194878 Clinical Trial.
Similar articles
-
Ticagrelor--is there need for a new player in the antiplatelet-therapy field?N Engl J Med. 2009 Sep 10;361(11):1108-11. doi: 10.1056/NEJMe0906549. Epub 2009 Aug 30. N Engl J Med. 2009. PMID: 19717845 No abstract available.
-
Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registry.Thromb Haemost. 2014 Feb;111(2):266-72. doi: 10.1160/TH13-06-0508. Epub 2013 Oct 31. Thromb Haemost. 2014. PMID: 24172891
-
Ticagrelor--a new platelet aggregation inhibitor in patients with acute coronary syndromes. An improvement of other inhibitors?Med Sci Monit. 2009 Dec;15(12):MS24-30. Med Sci Monit. 2009. PMID: 19946242 Review.
-
Ticagrelor in ACS: redefining a new standard of care?Lancet. 2010 Jan 23;375(9711):263-5. doi: 10.1016/S0140-6736(10)60070-0. Epub 2010 Jan 13. Lancet. 2010. PMID: 20079529 No abstract available.
-
Emerging P2Y12 receptor antagonists: role in coronary artery disease.Curr Vasc Pharmacol. 2010 Jan;8(1):93-101. doi: 10.2174/157016110790226615. Curr Vasc Pharmacol. 2010. PMID: 19485932 Review.
Cited by
-
Efficacy and Safety of Ticagrelor and Clopidogrel in Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.J Atheroscler Thromb. 2021 Aug 1;28(8):873-882. doi: 10.5551/jat.57265. Epub 2020 Sep 8. J Atheroscler Thromb. 2021. PMID: 32908113 Free PMC article.
-
Ticagrelor (brilinta), an antiplatelet drug for acute coronary syndrome.P T. 2012 Oct;37(10):562-8. P T. 2012. PMID: 23115464 Free PMC article.
-
Clinical pharmacodynamics and long-term efficacy of Talcom vs. Plavix in patients undergoing coronary stent implantation: a randomized study with 5-year follow-up.Eur J Clin Pharmacol. 2018 Nov;74(11):1397-1403. doi: 10.1007/s00228-018-2532-3. Epub 2018 Aug 20. Eur J Clin Pharmacol. 2018. PMID: 30128705 Clinical Trial.
-
Ticagrelor: a review of its use in the management of acute coronary syndromes.Drugs. 2011 May 7;71(7):909-33. doi: 10.2165/11206850-000000000-00000. Drugs. 2011. PMID: 21568367 Review.
-
P2Y12 Inhibitor Administration for Intracranial Stenting Procedures, the Usefulness of Efficiency Monitoring.J Neuroendovasc Ther. 2025;19(1):2025-0009. doi: 10.5797/jnet.oa.2025-0009. Epub 2025 May 31. J Neuroendovasc Ther. 2025. PMID: 40486913 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
